期刊文献+

晚期非小细胞肺癌患者应用顺铂化疗后MRP和LRP基因的表达 被引量:5

Clinical study of MRP and LRP mRNA expression in peple with human non-small cell lung cancer after cisplatin chemotherapy
在线阅读 下载PDF
导出
摘要 目的探讨多药耐药相关蛋白MRP(multidrug resistance associated protein,MRP)和肺耐药相关蛋白(lung resistance protein,LRP)在非小细胞肺癌中的基因表达及与顺铂耐药的关系。方法搜集化疗前后均有标本的非小细胞肺癌患者13例,应用RT-PCR法检测化疗前后MRP和LRP基因表达,Logistic回归分析法分析2种蛋白基因表达的相关性。结果与顺铂化疗前相比,化疗后患者MRP基因和LRP基因表达均显著增高(P<0.05),Logistic回归分析显示,2种蛋白的基因表达不具有相关性(r=O.036.P<0.05)。结论应用顺铂化疗后MRP和LRP基因表达增高,且2种蛋白的基因表达不具有相关性。 Objective To investigate the mRNA expression of the multidrug resistance associated protein and lung resistance protein in human non-small cell lung cancer tissues and their relationship with cis-platinum. Methods 13 samples were collected from patients with non small cell lung cancer before and after chemotherapy, the mRNA expression of MRP and LRP were detected using RT-PCR method, correlation between two genes were studied by Logistic regression analysis. Results Compared with before cisplatin chemotherapy, MRP and LRP expression of patients were increased after chemotherapy(P<0.05).Logistic regression analysis showed that there is no correlation between the two genes(r=0.036,P<0.05). Conclusion Cisplatin chemotherapy can increase the mRNA expression of MRP and LRP, and there is no correlation between the two genes.
作者 温志军
出处 《中国生化药物杂志》 CAS 北大核心 2014年第2期108-109,共2页 Chinese Journal of Biochemical Pharmaceutics
基金 山东省高校科技计划(J11LF75)
关键词 非小细胞肺癌 顺铂 多药耐药相关蛋白 肺耐药相关蛋白 non small-cell lung cancer cis-platinum complexes multidrug resistance associated protein lung resistance protein
  • 相关文献

参考文献9

二级参考文献94

  • 1王越,牛秀珑,郭小芹,吴健,朱雅琴,毛立群,屈野,李覃.卵巢癌细胞IL-6、IL-8分泌与其化疗敏感性及耐药相关基因和凋亡抑制基因表达关系的初步探讨[J].免疫学杂志,2009(4):436-441. 被引量:11
  • 2胡沙,王静,李智敏,郭剑锋,于利利,杨纯,王泽华.EZH2基因在人卵巢癌顺铂耐药株中的表达及其对细胞耐药性的影响[J].肿瘤,2010,30(9):748-752. 被引量:9
  • 3杨柳青,施毅,秦叔逵,钱军,韩宝惠,潘良熹,马胜林,李恩孝,蔡光蓉,李园,于国华,杨俊兰,王华庆,储大同.洛铂联合长春瑞滨治疗晚期非小细胞肺癌的临床研究[J].临床肿瘤学杂志,2006,11(12):890-894. 被引量:39
  • 4Alberto ME, Lucas MF, Pavelka M, et al. The secondgeneration anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism [ J ]. J Phys Chem B, 2009,113 (43) : 14473.
  • 5Kawai Y, Taniuchi S, Okahara S, et al. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation [ J ]. Biol Pharm Bull, 2005,28 (8) :1385.
  • 6Kurita H, Yamamoto E, Nozaki S,et al. Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma[ J ]. Cancer Chemother Pharmacol,2010,65 ( 3 ) :503.
  • 7Gong Y, Ren L,Zhou L, et al. Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma[J]. Cancer Chemother Pharmacol , 2009,64(2) :327.
  • 8Oshita F,Yamada K,Saito H,et al. Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer [ J ]. J Exp Ther Oncol,2004 ,4(4) :343.
  • 9Kuwahara A, Yamamori M, Nishiguchi K, et al. Replacement of cisplatin with nedaplatin in a definitive 5- fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma[ J]. Int J Med Sci,2009,6(6) :305.
  • 10Yamashita H, Nakagawa K, Tago M, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5- fluorouracil regimen: a retrospective study [ J ]. Dis Esophagus ,2006,19 ( 1 ) : 15.

共引文献74

同被引文献76

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部